PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 137 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,491,480 | -23.1% | 54,000 | -34.0% | 0.05% | -38.6% |
| Q1 2022 | $1,939,000 | -56.6% | 81,873 | -37.3% | 0.09% | -64.2% |
| Q4 2021 | $4,464,000 | +397.7% | 130,517 | +553.0% | 0.25% | +602.9% |
| Q2 2021 | $897,000 | -30.1% | 19,986 | -59.7% | 0.04% | -14.6% |
| Q1 2021 | $1,284,000 | +66.1% | 49,579 | +29.3% | 0.04% | +5.1% |
| Q4 2020 | $773,000 | +70.3% | 38,341 | +65.1% | 0.04% | +25.8% |
| Q3 2020 | $454,000 | -47.9% | 23,216 | -53.0% | 0.03% | -42.6% |
| Q2 2020 | $872,000 | – | 49,359 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |